Related Experiment Video
Updated: Jul 19, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
c-Jun NH2-terminal kinase promotes apoptosis by down-regulating the transcriptional co-repressor CtBP
Su-Yan Wang1, Mihail Iordanov, Qinghong Zhang
1Vollum Institute and Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, Oregon 97239, USA.
Abstract:
Genetic knock out of the transcriptional co-repressor carboxyl-terminal-binding protein (CtBP) in mouse embryonic fibroblasts results in up-regulation of several genes involved in apoptosis. We predicted, therefore, that a propensity toward apoptosis might be regulated through changes in cellular CtBP levels. Previously, we have identified the homeodomain-interacting protein kinase 2 as such a regulator and demonstrated that HIPK2 activation causes Ser-422 phosphorylation and degradation of CtBP. In this study, we found that c-Jun NH2-terminal kinase 1 activation triggered CtBP phosphorylation on Ser-422 and subsequent degradation, inducing p53-independent apoptosis in human lung cancer cells. JNK1 has previously been linked to UV-directed apoptosis. Expression of MKK7-JNK1 or exposure to UV irradiation reduced cellular levels of CtBP via a proteasome-mediated pathway. This effect was prevented by JNK1 deficiency. In addition, sustained activation of the JNK1 pathway by cisplatin similarly triggered CtBP degradation. These findings provide a novel target for chemotherapy in cancers lacking p53.
Insights
Genetic knockout of carboxyl-terminal-binding protein (CtBP) increases apoptosis. This study shows c-Jun NH2-terminal kinase 1 (JNK1) activation degrades CtBP, inducing cancer cell apoptosis, offering a new chemotherapy target.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Death Pathways
Background:
- Genetic disruption of carboxyl-terminal-binding protein (CtBP) leads to increased apoptosis.
- Cellular CtBP levels are hypothesized to regulate apoptosis propensity.
- Homeodomain-interacting protein kinase 2 (HIPK2) was previously identified as a CtBP regulator.
Purpose of the Study:
- To investigate the role of c-Jun NH2-terminal kinase 1 (JNK1) in regulating CtBP levels and apoptosis.
- To determine if JNK1-mediated CtBP degradation induces apoptosis in human lung cancer cells.
- To explore potential therapeutic strategies targeting CtBP degradation in cancer.
Main Methods:
- Investigated the effect of JNK1 activation on CtBP phosphorylation and degradation in human lung cancer cells.
- Utilized UV irradiation and cisplatin to activate the JNK1 pathway.
- Assessed CtBP levels and apoptosis induction in response to JNK1 activation and deficiency.
- Examined the role of the proteasome-mediated pathway in CtBP degradation.
Main Results:
- JNK1 activation triggers CtBP phosphorylation on Ser-422 and subsequent proteasomal degradation.
- This degradation induces p53-independent apoptosis in human lung cancer cells.
- UV irradiation and cisplatin-induced JNK1 activation reduce cellular CtBP levels.
- JNK1 deficiency prevents CtBP degradation and apoptosis induction.
Conclusions:
- JNK1-mediated degradation of CtBP represents a novel mechanism for inducing apoptosis.
- Targeting the JNK1-CtBP pathway offers a potential therapeutic strategy for cancers, particularly those lacking p53.
- This finding provides a new avenue for chemotherapy development in specific cancer types.
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Co-activators and Co-repressors
Caspases
Anaphase Promoting Complex
